Testing effectiveness (Phase 2)Study completedNCT00064142
What this trial is testing
Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
Who this might be right for
AIDS-related Kaposi SarcomaRecurrent Kaposi Sarcoma
National Cancer Institute (NCI) 30